Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KYNTRA BIO, INC.FGEN · Entity 7431 | Director | June 05, 2024 | June 07, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KYNTRA BIO, INC.
Report date June 05, 2024 · Filed June 07, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.21 · Expires 2034-06-04 | Direct | 70,000 |
Reported balance
After 2024-06-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-06-05 · Grant · Acquired 70,000 · Balance 70,000 F1: Options vest on the earlier of June 16, 2025 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Options vest on the earlier of June 16, 2025 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2024 Filed Jun 7, 2024 00:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001415889-24-015858 · form4-06062024_080614.xml · derivative · entry 1 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2034-06-04 F1 · derivative.exercise_date: Options vest on the earlier of June 16, 2025 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 23:53 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 12,666 | $0.00 Strike: $17.13 | $0.00 |
DisclosureSEC source: 0001209191-23-036077 · doc4.xml · derivative · entry 3 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,666 Underlying: Common Stock · 12,666 shares Expires 2033-06-06 F2 · derivative.exercise_date: Options vest on the earlier of June 7, 2024 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 23:53 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 8,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-036077 · doc4.xml · nonDerivative · entry 1 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,766 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 7, 2024 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 16, 2022 Filed Jun 22, 2022 01:06 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 25,684 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038599 · doc4.xml · derivative · entry 3 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,684 Underlying: Common Stock · 25,684 shares Expires 2032-06-15 F2 · derivative.exercise_date: Options vest on the earlier of June 16, 2023 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 16, 2022 Filed Jun 22, 2022 01:06 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 15,777 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038599 · doc4.xml · nonDerivative · entry 1 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,477 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 16, 2023 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $20.86 | $0.00 |
DisclosureSEC source: 0001209191-21-036682 · doc4.xml · derivative · entry 3 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2031-05-25 F2 · derivative.exercise_date: Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036682 · doc4.xml · nonDerivative · entry 1 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,400 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:31 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $32.69 | $0.00 |
DisclosureSEC source: 0001209191-20-035154 · doc4.xml · derivative · entry 3 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2030-06-03 F2 · derivative.exercise_date: Options vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:31 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035154 · doc4.xml · nonDerivative · entry 1 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,400 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 23:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $39.03 | $0.00 |
DisclosureSEC source: 0001209191-19-035658 · doc4.xml · derivative · entry 2 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2029-06-05 F2 · derivative.exercise_date: Options vest on the earlier of June 5, 2020 or the date of the next annual meeting of stockholders. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 23:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-035658 · doc4.xml · nonDerivative · entry 1 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,900 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 5, 2020 or the date of the next annual meeting of stockholders. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 23:35 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $55.30 | $0.00 |
DisclosureSEC source: 0001209191-18-036514 · doc4.xml · derivative · entry 2 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2028-06-05 F2 · derivative.exercise_date: Options vest on the earlier of June 6, 2019 or the date of the next annual meeting of stockholders. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 23:35 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 3,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-036514 · doc4.xml · nonDerivative · entry 1 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,200 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 6, 2019 or the date of the next annual meeting of stockholders. Read SEC document |
| December 04, 2017 Filed Dec 6, 2017 00:45 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | PurchaseCommon Stock | 3,500 | $46.70 | $163,450.00 |
DisclosureSEC source: 0001209191-17-064075 · doc4.xml · nonDerivative · entry 1 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Read SEC document |
| September 19, 2017 Filed Sep 22, 2017 00:02 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 8,614 | $0.00 Strike: $53.50 | $0.00 |
DisclosureSEC source: 0001209191-17-053662 · doc4.xml · derivative · entry 2 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,614 Underlying: Common Stock · 8,614 shares Expires 2017-09-19 F2 · derivative.exercise_date: The shares subject to the option vest and become exercisable as follows: 2,614 shares on December 7, 2017; 3,000 on March 7, 2018; and 3,000 on June 7, 2018. Read SEC document |
| September 19, 2017 Filed Sep 22, 2017 00:02 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $53.50 | $0.00 |
DisclosureSEC source: 0001209191-17-053662 · doc4.xml · derivative · entry 1 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2017-09-19 F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable quarterly over three years measured from September 19, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.